Brainjuicer Group Plc operates in the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Brainjuicer Group Plc with three other
miscellaneous service companies in Europe:
Zealand Pharma A/S
sales of 234.78 million Danish Kroner [US$34.08 million]
Karo Pharma AB
(347.26 million Swedish Kronor [US$39.47 million]
Oxford BioMedica plc
(£27.78 million [US$34.68 million]
Brainjuicer Group Plc reported sales of £31.24 million (US$39.00 million)
December of 2016.
increase of 24.0%
versus 2015, when the company's sales were £25.18 million.
Sales at Brainjuicer Group Plc have increased during each of the previous five years
(and since 2011, sales have increased a total of 51%).